Literature DB >> 25925756

Patterns and variations in microvascular decompression for trigeminal neuralgia.

Hiroki Toda1, Masanori Goto, Koichi Iwasaki.   

Abstract

Microvascular decompression (MVD) is a highly effective surgical treatment for trigeminal neuralgia (TN). Although there is little prospective clinical evidence, accumulated observational studies have demonstrated the benefits of MVD for refractory TN. In the current surgical practice of MVD for TN, there have been recognized patterns and variations in surgical anatomy and various decompression techniques. Here we provide a stepwise description of surgical procedures and relevant anatomical characteristics, as well as procedural options.

Entities:  

Mesh:

Year:  2015        PMID: 25925756      PMCID: PMC4628171          DOI: 10.2176/nmc.ra.2014-0393

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


Introduction

Based on the early recognition of neurovascular compression in patients with trigeminal neuralgia (TN) by Dandy in the 1930s,[1,2)] the pioneering works of Gardner and Miklos[3)] and of Janneta[4–6)] established microvascular decompression (MVD) as a surgical procedure during 1950–1960s. Since then, MVD has been developed to be an effective surgical treatment for TN, while various additional surgical treatments have further been pursued (Table 1). Observational studies have suggested that MVD with good pain management is beneficial, as it is the only non-ablative surgical procedure available.[7)] The basic principle of MVD is to separate the compressing vessels from the trigeminal nerve. Most recently, studies on the use of MVD for TN treatment have focused on improving elaborate surgical techniques. The aim of this review is to describe the anatomical and surgical patterns and variations of MVD for TN. We illustrate the surgical anatomy at each step of the procedure and review various modifications of fundamental decompression techniques.
Table 1

History of surgery for trigeminal neuralgia

YearAuthorsProcedures
1900Cushing[56)]Gasserian ganglion removal
1901Spiller, Frazier[57)]Selective subtemporal rhizotomy with sparing the motor root
1911Taptas[58)]Alcohol injection into Meckel’s cave
1932Kirschner[59)]Percutaneous coagulation of gasserian ganglion
1932Dandy[1)]Posterior fossa subtotal Rhizotomy
1934Dandy[2)]Recognition of vascular compression as a cause of neuralgia
1947Olivecrona[60)]Subtemporal rhizotomy
1952Taarnhøj[61)]Intradural decompression of the gasserian ganglion and the posterior root
1952Love[62)]Extradural decompression of the gasserian ganglion and the posterior root
1955Shelden[63)]Enlarging the foramen oval and foramen rotundum
1959Gardner, Miklos[3)]First report of vascular decompression
1966Jannetta, Rand[64)]Transtentorial retrogassellian microvascular decompression
1971Jannetta[5)]Retromastoid microvascular decompression
1974Sweet, Wepsic[65)]Percutaneous radiofrequency trigeminal rhizotomy
1981Håkanson,[66)] Sweet[67)]Glycerol injection rhizotomy
1983Mullan, Lichtor[68)]Balloon catheter rhizotomy
1993Rand[69)]Gamma Knife
1996Ebel[70)]Motor cortex stimulation for facial pain

Nine Surgical Steps with Relevant Surgical Anatomy

Preoperative planning

Preoperative x-ray, computed tomography (CT), and magnetic resonance imaging (MRI) and angiography (MRA) provide morphometric information on the posterior fossa and the neurovascular structures of the trigeminal nerve. The authors routinely refer to the checklist presented in Table 2 to evaluate anatomical checkpoints as revealed by these imaging techniques; representative images are shown in Fig. 1A–F.
Table 2

Preoperative imaging checklist

Anatomical checkpointsModalities
Skull morphometry and extent of mastoid air cellsX-ray, CT, MRI
Surface landmarks for the junction of the transverse and sigmoid sinusesCT
Presence of the subdural spaces and width of the cerebellopontine cisternMRI
Position of the superior petrosal vein in the mediolateral aspectCT, MRI
Identification of the vessel(s) compressing the trigeminal nerveMRI

CT: computed tomography, MRI: magnetic resonance imaging.

Fig. 1.

Preoperative imaging. A: Lateral x-ray view shows the morphometry of the posterior fossa. Twining line (TL) from tuberculum sellar (TS) to the internal occipital protuberance (IOP), McRae line (ML) from basion (Ba) to opisthion (Op). The extent of the mastoid air cells is shown (arrowheads). B: The posterior margin of the mastoid air cells (dashed line) is posterior to the edge of the sigmoid sinus (solid line). C: Surface landmarks to identify the junction of the transverse and sigmoid sinuses and the Frankfurt plane projected onto the skull surface (dashed line) are shown. The orifice of the emissary vein is marked with triangles on the surface and multiplanar image. D: Trigeminal nerve and vascular complex (arrow) in a narrow prepontine cistern (triangles). E: Entrance of the superior petrosal vein (arrow, also in black arrow in F) into the superior petrosal sinus on contrast enhanced CT. F: Heavy T2 images show a distorted trigeminal nerve (arrowhead) compressed with the superior loops of the cerebellar (white arrows) and anterior inferior cerebellar (open arrow) arteries. CT: computed tomography, SO: supraocciput.

A detailed identification of areas indicating neurovascular compression is the most important component of the preoperative evaluation. Cisternographic heavy T2-weighted images and angiographic time-of-flight images are often merged to visualize the vessels compressing the trigeminal nerve root. Representative heavy T2 sequences include constructive interference in steady state (CISS),[8)] fast imaging employing steady-state acquisition (FIESTA),[9)] true fast inflow with steady-state precession (FISP),[10)] and three-dimensional (3D) fast asymmetric spin echo (FASE).[11)] In addition, 3D coronal[12)] and multiplanar reconstruction (MPR) images[13)] are useful for visualizing the neurovascular contacts, and the 3D surface-rendering virtual endoscopic view can provide clear images of the neurovascular relationship.[14,15)] A meta-analysis of MRI/MRA findings from nine blinded case control studies[16)] indicated that significant neurovascular contacts in the trigeminal nerve were observed more frequently with symptomatic nerves than with asymptomatic nerves (89% vs. 36%). The accuracy of neurovascular compression findings on MRI showed high sensitivity (75–95%) but varying specificity (26–86%). Anatomical changes found on MRI, such as atrophy, distortion, or flattening of the trigeminal nerve, were significantly more frequently observed in symptomatic nerves (53% vs. 9%). The diagnostic accuracy of anatomic changes in symptomatic nerves displayed wide variation in sensitivity (20–74%), but moderate variation in specificity (79–100%).

Anesthesia and position

Under general anesthesia, the patient is placed in the lateral decubitus position or spine position and the eyes are taped shut after applying ointment to avoid corneal abrasion. The auditory evoked brainstem response (AEBR) is used to monitor ipsilateral hearing function. The AEBR signals are recorded from electrodes at A1/A2-Cz. Trigeminal laser-evoked potentials may be used to monitor post-surgical outcomes.[17)] In our surgical practice, we use the lateral decubitus position with the head on the headrest and the contralateral arm held under the table (Fig. 2A). The trunk and head are rotated slightly away to the contralateral side (Fig. 2B). The neck is flexed slightly to improve the surgeon’s visibility along the caudo-rostral direction (Fig. 2C). To allow for more convenient placing of disk electrodes for monitoring AEBR, Fz can be used instead of Cz without the loss of monitoring quality.
Fig. 2.

Patient in a lateral recumbent position. A: The patient’s shoulder is slightly retracted downward with an elastic band (solid line). The neck is slightly tilted for the vertex down position (white arrow). B: The trunk (solid line) and head are slightly rotated away (arrow) to the contralateral side. C: The neck is flexed (solid line) to allow visibility along the caudo-rostral direction (arrow).

Incision

The skin incision made to expose the retromastoid area can be either linear or curved linear. In our surgical practice, we place a 6–8 cm linear incision behind the mastoid process along the hairline (Fig. 3A). The central point of the incision is located at the mastoid notch. The incision for TN is placed medial and upward to the incision for hemifacial spasm, because of the differences in the operative fields and optic axes. The scalp and the underlying posterior auricular and sternocleidomastoid muscles are cut. Bleeding from the orifices of the emissary veins on the skull is controlled with minimum bone wax. Excessive bone wax may be pushed into the venous sinus. The occipital artery and other vessels in the fascia are coagulated and cut. The underlying splenius capitis, semispinalis capitis, and longissimus muscles are cut sequentially. The obliquus capitis superior muscle is detached partially in patients with a small posterior cranial fossa.
Fig. 3.

Retrosigmoid approach A: A curved-linear skin incision along the hairline with minimal shaving. The midpoint of incision is placed at the superior end of the mastoid notch. B: A dural incision can be U- (solid line), T- (round dotted line), or L-shaped (dashed line) along the venous sinus. C: The first intradural landmarks are the petrous dura (P), tentorium (T), and petrotentorial junction (J).

Craniotomy/craniectomy

The bone window is made by craniotomy or craniectomy to expose the borders of the transverse and sigmoid sinuses and their junction (Fig. 3B). The Frankfurt horizontal plane, asterion, mastoid tip, and orifices of the emissary veins are used as surface landmarks to predict the positions of the transverse and sigmoid junction (Fig. 1C).[18–20)] The relative distances to these landmarks are variable, therefore, individualization with 3D-reconstructed CT is useful.[21)] The authors prefer craniotomy to facilitate reconstruction of the bone window at closing. The direction of the perforator should be carefully controlled to avoid damaging the sinus. The mastoid air cells are sealed when they are opened to minimize fluid collection. In elderly patients, the venous sinus wall often adheres to the inner table of the occipital bone and care should be taken to avoid sinus injury. In cases of a small or tight posterior fossa, the caudal end of bone opening is widened below the inferior nuchal line.

Dural opening

The dural incision can be a U-, T-, or L-shaped cut (Fig. 3B). Bleeding from the dura is controlled with tacking sutures or minimum cauterization to avoid dural shrinkage. Bleeding near the sinuses can be controlled with oxidized cellulose and fibrin glue, as cauterization may enlarge the opening of the bleeding point.

Cerebrospinal fluid (CSF) release

After dural opening, CSF is then drained. In young patients or those with small posterior fossa, the cerebellomedullary cistern or cisterna magna is open to drain CSF. A lumbar drain is an alternative. By opening the supracerebellar and cerebellopontine cisterns, the petrotentorial junction can be observed (Fig. 3C) and the cerebellar surface is then covered with cottonoid on a rubber dam.

Exposure of the superior petrosal vein, trigeminal nerve, and compressing vessels

Further opening of the cerebellopontine cistern along the petrotentorial junction reveals the superior petrosal vein (SPV) and its tributaries (petrosal vein complex). A tapered retractor blade can be placed over the superolateral aspect of the cerebellar surface. Thorough arachnoid dissection and gravity retraction by tilting the operating table can also open the cerebellopontine angle without using a retractor blade. The arachnoid around the petrosal vein complex is dissected, while the arachnoid over the facial and auditory/vestibular nerve complex is left intact (Fig. 4A). Some experts instruct cutting of the SPV;[4,22)] however, it is difficult to estimate the safety of coagulation of the SPV. Meticulous cutting of the arachnoid over the petrosal vein complex (Fig. 4B) enables us to observe the trigeminal nerve from various angles. Cutting the arachnoid over the petrosal (horizontal) fissure and superior limb of the cerebellopontine fissure (Fig. 4C) also provides wide exposure of the trigeminal nerve root (Fig. 4D). The large suprameatal tubercle[23)] (Fig. 4E) is partially resected by drilling (Fig. 4F) to observe the trigeminal nerve root clearly (Fig. 4G). Complete dissection of the cerebellopontine angle near the petrotentorial junction is a key step prior to the decompression procedure.
Fig. 4.

Making a corridor to the trigeminal nerve root. A, B: A right trigeminal neuralgia (TN) case. Arachnoid over the superior petrosal vein and venous complex should be dissected. Note the superior anterior hemispheric (AH) vein enters the superior petrosal sinus (asterisk) lateral to the superior petrosal (SP) vein in the illustrated case. After arachnoid dissection, the SCA is mobilized with a suction tube and microinstruments (B). C, D: A left TN case. After the arachnoid over the horizontal fissure (arrowheads) is dissected, the trigeminal nerve root and the anterior inferior cerebellar artery (AICA, AI) are observed. E–G: A right TN case. The dura over the suprameatal tubercle (SMT) is stripped (E) and the SMT is drilled with diamond burr (F). The trigeminal nerve root is compressed by the SCA and AICA. CP: vein of cerebellopontine fissure, PT: pontotrigeminal vein, S: superior cerebellar artery (SCA), T: trigeminal nerve.

Decompression procedure

The trigeminal nerve should be inspected from the brainstem to the Meckel’s cave. As noted in Jannetta’s principles,[4)] finding the compressing vessels along the trigeminal nerve root is a surgeon’s task. We must be mindful that the compressing vascular structures may include multiple vessels or a single small vein. Thorough observation of the trigeminal nerve is the most important consideration. Endoscopy may be useful for further confirmation.[24–26)] Vascular decompression techniques can be classified as interposition or transposition. Simple insertion of a prosthesis between the trigeminal nerve and compressing artery should be avoided. The artery should be freed and mobilized from the original compression site before inserting the prosthesis.[4)] To transpose the vessels, mobilized vessels are fixed to the tentorium or the petrous dural surface. The types of prostheses used for interpositions and various techniques of decompression are listed in Table 3.
Table 3

List of prostheses and techniques used for microvascular decompression

Prosthesis and techniques
Polytetrafluoroethylene (Teflon®)[30,71)]
Polyvinyl alcohol sponge (Ivaron®)[30)]
Polyurethane sponge[72)]
Silicone sponge [73,74)]
Vascular tape[75)]
Fibrin glue[25,76)]
Collagen sheet (Surgicel®, TachoComb®)[31)]
Cyanoacrylate (Aron Alpha®)[77)]
Aneurysm clip[78)]
Titanium plate, protecting trigeminal nerve[32)]
Thread[29)]
Dura, tentorial sling[79)]
Arachnoid sling[80)]

Aron Alpha®: DaiIchi Sankyo, Tokyo; Ivaron®: Ivalon Surgical Products, Eudora, KS, USA; Surgicel®: Johnson&Johnson, Tokyo; TachoComb®: CSL Behring, Tokyo; Teflon®: Bard, Tempe, AZ, USA.

The size and shape of the bone window and the extent of arachnoid dissection should be modified according to the type of the compressing vessels. The superior cerebellar artery (SCA), which is the most frequently observed compressing vessel, is dissected from superomedial aspects of the trigeminal nerve (Fig. 5A, B). The perforating branches from the SCA are often observed during the neurovascular dissection (Fig. 5C). Most of these perforating branches are the long circumflex type,[27)] and rarely restrict mobilization. The vascular loop is separated from the trigeminal nerve (Fig. 5D) and fixed to the tentorial surface with fibrin glue (Fig. 5E, F). The anterior inferior cerebellar artery (AICA), which is the next most common compressing vessel, is dissected from caudal aspects of the trigeminal nerve. Perforating arteries from the AICA are usually short and restrict mobilization. The SPV and its draining veins sometimes compress the nerve root. Empirically, the pontotrigeminal and transverse pontine veins can be coagulated and cut due to their collateral circulation. The vertebrobasilar artery may cause TN as painful tic convulsif and other manifestations of combined hyperactive dysfunction syndrome.[28)] Previous case reports have demonstrated various mobilization techniques using thread,[29)] tapes,[30)] or adhesive glues.[31)] In addition, a unique procedure using a titanium plate to protect the trigeminal nerve from the megadolicobasilar artery has been reported.[32)] Arterial anomalies such as persistent primitive trigeminal artery,[33)] primitive trigeminal artery variants,[34,35)] and cerebellotrigeminal artery[36)] are reported to be the causes of TN. Another variation of TN is compression by the intraneural vessels. Intraneural veins[37)] can be coagulated, while intraneural arteries[38,39)] require wrapping, mobilization away from the original compression site, and rhizotomy. If no compressing vessel is found, then it is possible that a vascular loop may be moved away from the nerve root during CSF drainage. Such a vascular loop should be transposed and fixed to the dura. The surgeon also may consider rhizotomy in such cases.
Fig. 5.

Mobilization of the superior cerebellar artery (SCA) in a right trigeminal neuralgia case. A: The arachnoid around the superior petrosal (SP) vein and its tributaries has been dissected. The SCA (S) and its bifurcation compress the trigeminal nerve (T). B: The SCA is separated from the trigeminal nerve by gentle dissection around the SCA. C: Perforating arteries from the SCA (arrowhead) should be carefully dissected. D: Complete separation of vascular structure from the trigeminal nerve. E: The laterally mobilized SCA is fixed on the tentorial dura (Te) with glue (circle). Complete arachnoid dissection between the trigeminal nerve and SCA is confirmed (dashed circle). F: Illustrated scheme of vascular mobilization for the SCA loop. The SCA and its bifurcation (x) compressing the trigeminal nerve root (dashed circle) are shown in dark red. The mobilized and transposed SCA (S’) with its bifurcation (x’) is shown in red. Lateral mobilization of the SCA (arrow) flattens the vascular loop (dashed lines) and separates the SCA from the trigeminal nerve. ALM: anterior lateral marginal vein, AHV: anterior hemispheric vein, CP: vein of cerebellopontine fissure, SCA: superior cerebellar artery.

In recurrent and incompletely treated cases, compression may be due to arachnoidal adhesions, previously unidentified vessels, or an interposed prosthesis, which sometimes generates granulomas.[40)] Meticulous dissection of the adhesion must be carried out to avoid injury to the hidden perforating arteries. If the prosthesis is tightly adhered to the trigeminal nerve, it can be left on the surface of the nerve after removing most of the tissue. Microscissors with serrated blades are useful to cut tough synthetic fibers of some prostheses.

Closure

Before closing the dura, valsalva maneuvers are useful to confirm complete hemostasis. The dura is closed with interrupted 4-0 Nurolon sutures. Application of gelatin sponges onto the dural surface can be used to moisten the dura and help ensure a watertight closure. The bone edges of the mastoid air cells should be thoroughly waxed again. Several collagen sheets are placed over the closure line and fibrin glue is then sprayed over them. The subdural space is filled with warm artificial CSF or saline. Syringe irrigation should be used carefully with a jet of fluid to avoid tissue injury. The bone flap can be fixed with a small titanium plate and screws and bone dust collected at craniotomy is used to fill in gaps around the flap. Osteoplastic craniotomy or reconstruction of the bone window is useful to reduce wound-related complications. The fascia layers and subcutaneous tissues are approximated with interrupted absorbable sutures. The fascia closure of the superficial muscles must be watertight. The skin is closed with staples or sutures.

Outcomes and Clinical Evidence

A recent systematic review on MVD for TN[41)] including 26 articles from 2000 to 2013 described a mean pain-free success rate of 83.5% and complication rates of 1.3–9.1%. The postoperative mortality is 0.1%. Another systematic meta-analysis suggested that the most elderly patients (> 65 years of age) with TN can safely undergo MVD with excellent outcomes.[42)] Outcomes are generally superior in high-volume units that see 20 TN admissions per year and for surgeons with more than 29 annual surgical cases.[43)] Practice parameters and guidelines published in 2008 by the American Academy of Neurology[44)] and the European Federation of Neurological Societies[45)] also indicated that 90% of patients underwent MVD obtain pain relief. Major complications such as CSF leaks, infarcts, or hematomas are seen in 0.7–4% of patients. Aseptic meningitis occurs in 11% of patients; facial numbness in 1.3–19.6%; and facial weakness in 0.5–6.2%. Hearing loss is a major long-term complication in 0.2–3.9% or as many as 10% of patients. Incisional infection occurs in 0.1–2.5% of patients. The average mortality associated with the operation is 0.2%, though rates as high as 0.5% have been reported.[44)] Acute withdrawal of carbamazepine should be avoided because it causes radiographical changes in the splenium of the corpus callosum.[46)] Symptom recurrence is seen in 11% of patients who resorted to repeated MVD.[41)] The greatest number of recurrences occurs in the first 2 years.[47)] Over 80% will remain pain-free at 1 year, 75% at 3 years, and 73% at 5 years.[44,45)] Seventy percent of patients may remain pain-free without medication for up to 10 years.[48)] Clinical evidence that supports the benefit of MVD for TN are limited by a lack of randomized control trials; there have been three prospective cohort studies (possible Class II)[42,49,50)] and a limited number of Class III reports with independent outcomes assessment.[48,51–54)] The vast majority of studies have been Class IV. The practice parameters[44)] and guidelines[45)] have considered surgical interventions for patients with medically refractory TN as Level C. The guidelines have noted that MVD may be considered over other surgical interventions because MVD provides the longest duration of pain control. Additional prospective studies on MVD for TN must be well-designed and meet high evidentiary standards.[55)]

Conclusion and Perspectives

MVD for TN has a high success rate with low risk of morbidity and very low risk of mortality. Surgeons should be familiar with various patterns of neurovascular compressions and decompression techniques. Further studies on advanced high-resolution structural and functional neuroimaging analysis, investigations directly addressing the appropriate timing of surgical interventions, and well-designed prospective trials would be useful to improve the management of TN.
  73 in total

Review 1.  Microvascular decompression surgery for trigeminal neuralgia and hemifacial spasm: naunces of the technique based on experiences with 100 patients and review of the literature.

Authors:  Aaron A Cohen-Gadol
Journal:  Clin Neurol Neurosurg       Date:  2011-07-14       Impact factor: 1.876

2.  Tic douloureux caused by primitive trigeminal artery or its variant.

Authors:  A Morita; T Fukushima; S Miyazaki; T Shimizu; M Atsuchi
Journal:  J Neurosurg       Date:  1989-03       Impact factor: 5.115

3.  A tentorial sling in microvascular decompression for trigeminal neuralgia. Technical note.

Authors:  R L Melvill; B L Baxter
Journal:  J Neurosurg       Date:  1996-01       Impact factor: 5.115

4.  The long-term outcome of microvascular decompression for trigeminal neuralgia.

Authors:  Zaid Sarsam; Marta Garcia-Fiñana; Turo J Nurmikko; Thelekat R K Varma; Paul Eldridge
Journal:  Br J Neurosurg       Date:  2010-02       Impact factor: 1.596

Review 5.  Combined hyperactive dysfunction syndrome of the cranial nerves: trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia: 11-year experience and review.

Authors:  H Kobata; A Kondo; K Iwasaki; T Nishioka
Journal:  Neurosurgery       Date:  1998-12       Impact factor: 4.654

6.  Vascular contact with the fifth cranial nerve at the pons in patients with trigeminal neuralgia: detection with 3D FISP imaging.

Authors:  J F Meaney; J B Miles; T E Nixon; G H Whitehouse; E S Ballantyne; P R Eldridge
Journal:  AJR Am J Roentgenol       Date:  1994-12       Impact factor: 3.959

7.  Trigeminal neuralgia treated by the injection of glycerol into the trigeminal cistern.

Authors:  S Håkanson
Journal:  Neurosurgery       Date:  1981-12       Impact factor: 4.654

8.  A prospective cohort study of microvascular decompression and Gamma Knife surgery in patients with trigeminal neuralgia.

Authors:  Mark E Linskey; Vaneerat Ratanatharathorn; Jose Peñagaricano
Journal:  J Neurosurg       Date:  2008-12       Impact factor: 5.115

9.  Trigeminal laser-evoked potentials: a neurophysiological tool to detect post-surgical outcome in trigeminovascular contact neuralgia.

Authors:  G Squintani; M Turri; F Donato; M Tinazzi; B Masotto; V Tramontano; A Talacchi; F Sala; G Moretto; M Valeriani
Journal:  Eur J Pain       Date:  2014-07-28       Impact factor: 3.931

10.  Trigeminal neuralgia caused by persistent primitive trigeminal artery.

Authors:  Chang Kyu Park; Hyuk Jai Choi; Sung Ho Lee; Bong Arm Rhee
Journal:  J Korean Neurosurg Soc       Date:  2014-09-30
View more
  3 in total

Review 1.  Update on Trigeminal Neuralgia.

Authors:  Alexander X Tai; Vikram V Nayar
Journal:  Curr Treat Options Neurol       Date:  2019-07-31       Impact factor: 3.598

2.  Global Trends and Hotspots in Trigeminal Neuralgia Research From 2001 to 2021: A Bibliometric Analysis.

Authors:  Ganggui Zhu; Zaixiang Fu; Sheng Su; Yajuan Tang; Fuyi Liu; Wenhua Yu
Journal:  Front Neurol       Date:  2022-05-10       Impact factor: 4.086

3.  Efficacy and Prognostic Value of Partial Sensory Rhizotomy and Microvascular Decompression for Primary Trigeminal Neuralgia: A Comparative Study.

Authors:  Jian Gao; Yao Fu; Shi-Kun Guo; Bing Li; Zhong-Xin Xu
Journal:  Med Sci Monit       Date:  2017-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.